Evaluating Medication Adherence in Type-2 Diabetes: A Study of Drug Therapy Using the Medication Adherence Report Scale (MARS).

Authors

  • Rubeena Kauser
  • Shankaraiah Puligilla

Keywords:

Diabetes patients, medication adherence, MARS, scale, dual therapy and combinations

Abstract

Objective: This study sought to evaluate the medication adherence and improvements in the diabetic patients using different combination therapies.

Materials and method: This cross-sectional study included 193 T2D patients aged 18-80 years, receiving treatment for at least six months. The Medication Adherence Rating Scale (MARS) was used to assess medication adherence. Multiple regression and descriptive statistics were used to evaluate the data and find adherence predictors.

Results: According to the statistics, dual therapy showed the greatest improvement in medication adherence, followed by triple therapy. The single therapy showed the least improvement in medication adherence, at 25%. There is a better adherence score for both triple therapy and dual therapy, as the research shows that the mean difference for triple therapy is the biggest, followed by dual therapy.

Conclusion: The differing effectiveness of therapy approaches suggests that both physiological and behavioral outcomes should be considered when choosing a treatment to optimize patient care. The study's findings support the application of patient-centered, multifaceted diabetic treatment approaches that consider the complex interplay between clinical efficacy and adherence behaviors.

Downloads

Download data is not yet available.

References

[1] Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011 Sep;3(9):418-23. doi: 10.4297/najms.2011.3418. PMID: 22362451; PMCID: PMC3271397.

[2] Sahoo J, Mohanty S, Kundu A, Epari V. Medication Adherence Among Patients of Type II Diabetes Mellitus and Its Associated Risk Factors: A Cross-Sectional Study in a Tertiary Care Hospital of Eastern India. Cureus. 2022 Dec 29; 14(12):e33074. doi: 10.7759/cureus.33074. PMID: 36721541; PMCID: PMC9883658.

[3] Huang J, Ding S, Xiong S and Liu Z (2021) Medication Adherence and Associated Factors in Patients with Type 2 Diabetes: A Structural Equation Model. Front. Public Health 9:730845. doi: 10.3389/fpubh.2021.730845

[4] Yuvaraj, K.1,; Gokul, S.1; Sivaranjini, K.1; Manikandanesan, S.1; Murali, Sharan1; Surendran, Gayathri1; Majella, Marie Gilbert1; Kumar, S. Ganesh1. Prevalence of medication adherence and its associated factors among patients with noncommunicable disease in rural Puducherry, South India – A facility-based cross-sectional study. Journal of Family Medicine and Primary Care 8(2):p 701-705, February 2019. | DOI: 10.4103/jfmpc.jfmpc_350_18

[5] Türen, Sevda & Atakoğlu, Rahime & Gundogdu, Seval. (2022). Original Article The Relationship with Acceptance of Illness and Medication Adherence in Type 2 Diabetes Mellitus Patients. 3-1824.

[6] Rezaei, M., Valiee, S., Tahan, M., Ebtekar, F., & Ghanei Gheshlagh, R. (2019). Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 589–599.

[7] Hadjadj S, Rosenstock J, Meinicke T, Woerle HJ & Broedl UC (2016) Initial Combination of Empagliflozin and Metformin in Patients with Type 2 Diabetes. Diabetes Care, 39, 1718–1728. [PubMed: 27493136]

[8] Henry RR, Murray AV, Marmolejo MH, Hennicken D, Ptaszynska A & List JF (2012) Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial. Int J Clin Pract, 66, 446–456. [PubMed: 22413962]

[9] Rosenstock J, Chuck L, Gonzalez-Ortiz M, Merton K, Craig J, Capuano G & Qiu R (2016) Initial Combination Therapy with Canagliflozin Plus Metformin versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes. Diabetes Care, 39, 353–362. [PubMed: 26786577]

[10] Xie X, Wu C, Hao Y, Wang T, Yang Y, Cai P, Zhang Y, Huang J, Deng K, Yan D and Lin H (2023) Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. Front. Endocrinol. 14:1301093. doi: 10.3389/fendo.2023.1301093

[11] Venkatesan M, Dongre AR, Ganapathy K. A Community-Based Study on Diabetes Medication Nonadherence and its Risk Factors in Rural Tamil Nadu. Indian J Community Med. 2018 Apr-Jun;43(2):72-76. doi: 10.4103/ijcm.IJCM_261_17. PMID: 29899603; PMCID: PMC5974838.

[12] Mukherjee S, Sharmasarkar B, Das KK, Bhattacharyya A, Deb A. Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in kolkata, India. J Clin Diagn Res. 2013 Apr; 7(4):661-5. doi: 10.7860/JCDR/2013/5352.2876. Epub 2013 Feb 15. PMID: 23730641; PMCID: PMC3644439.

[13] Sharma T, Kalra J, Dhasmana D, Basera H. Poor adherence to treatment: A major challenge in diabetes. Age (Yrs). 2014; 31(40):40.

[14] Jha BN, Dastidar DG, Tyagi M, Jaiswal AK,A Cross-Sectional Study on the Relationship Between Medication Adherence and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Mellitus Patients.International Journal of Pharmaceutical Quality Assurance 2025; 16(5); 152-160

[15] Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, Holst EM, Nichol MB, Shi SG, Livengood KB, Walden S, Lubowski TJ. Medication adherence and associated hemoglobin A1C in type 2 diabetes. Ann Pharmacother. 2004 Sep; 38(9):1357-62.

[16] Esquivel-Prados E, Pareja-Martínez E, García-Corpas JP. Relationship between adherence to oral antidiabetic drugs and control of type 2 diabetes mellitus. J Healthc Qual Res. 2024 Nov-Dec; 39(6):346-355. doi: 10.1016/j.jhqr.2024.06.007. Epub 2024 Jul 23. PMID: 39048410.

[17] Amani Khardali, Nabeel Kashan Syed, Saad S. Alqahtani, Marwa Qadri, Abdulkarim M. Meraya, Norah Rajeh, Fatimah Aqeely, Sedan Alrajhi, Amnah Zanoom, Shahd Gunfuthi, Wahhaj Basudan, Thana K. Hakami, Mawada A. Abdelgadir, Assessing medication adherence and their associated factors amongst type-2 diabetes mellitus patients of Jazan Province, Saudi Arabia: A single-center, cross-sectional study. Saudi Pharmaceutical Journal, Volume 32, Issue 1, 2024, 101896, ISSN 1319-0164

[18] Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs. [1 March 2012]Page no: 1227.

Downloads

Published

2025-08-19

How to Cite

1.
Kauser R, Puligilla S. Evaluating Medication Adherence in Type-2 Diabetes: A Study of Drug Therapy Using the Medication Adherence Report Scale (MARS). J Neonatal Surg [Internet]. 2025 Aug. 19 [cited 2026 Apr. 14];14(32S):10422-9. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9949

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.